Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,325 public trials 1,974 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

NCT04348747

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, Brain Neoplasms, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • University of Virginia Comprehensive Cancer Center Charlottesville, Virginia, United States
View Trial Details
Recruiting

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

NCT05111561

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Texas Medical Branch Galveston, Texas, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

NCT03606967

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
View all 30 locations
View Trial Details
Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

NCT06827236

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +6 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Hematology - Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer & Blood Center, LLC Athens, Georgia, United States
View all 68 locations
View Trial Details
Recruiting

ATEMPT 2.0: Adjuvant T-DM1 vs TH

NCT04893109

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Smilow Cancer Hospital Care center at Derby Derby, Connecticut, United States
  • Smilow Cancer Hospital Care center at Fairfield Fairfield, Connecticut, United States
  • Smilow Cancer Hospital Care center at Glastonbury Glastonbury, Connecticut, United States
View all 53 locations
View Trial Details
Recruiting

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

NCT04751435

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +38 more
Locations
  • Kings County Hopsital Center Brooklyn, New York, United States
  • Queens Cancer Center of Queens Hospital Jamaica, New York, United States
  • Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities) New York, United States
  • Jamaica Hospital Medical Center (Data Collection Only) Richmond Hill, New York, United States
View Trial Details

Related conditions